NCT05452356 Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)
| NCT ID | NCT05452356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Condition | Heart Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-04-18 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-04-18 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with various cardiac conditions (such as those who experience a heart attack) are increasing in Canada and are in need of appropriate cardiac rehabilitation and care. Many patients do not have access to local in-person cardiac clinics, particularly in rural regions of Canada. A user-friendly digital application with accessible educational resources and recommendations based on the most up to date clinical practice guidelines can help mitigate these issues. VIRTUES is a digital healthcare application that targets 11 modifiable modules as follows: 1. antithrombotic management 2. lipid management 3. rate and rhythm control for atrial fibrillation 4. heart failure care 5. post myocardial infarction care 6. blood sugar management 7. blood pressure management 8. physical activity 9. healthy eating 10. smoking cessation 11. alcohol reduction Of the 11 total modules, the first 7 listed provide recommendations in VIRTUES. The remaining 4 (physical activity, healthy eating, smoking cessation and alcohol reduction) consist of simple referrals to existing recommendations (i.e., for healthy eating and physical exercise) and referrals to existing local programs (i.e., for smoking cessation and alcohol reduction). Thus, in this cohort study, the investigators will test the primary 7 modules with 200 patients per module for approximately one month each in order to obtain feedback on the usability of each module. The investigators will also conduct virtual focus group discussions to obtain open ended feedback on the application. This study will provide valuable feedback, which will be used to improve and adapt the VIRTUES platform.
Eligibility Criteria
Inclusion Criteria: * Any patient with a cardiovascular condition. * Ability to provide informed consent. * Proficient in the English language. * Access to a device capable of running mobile application. * Used mobile technology within the past 3 months. Exclusion Criteria: * Any medical condition making 1-month survival unlikely.
Contact & Investigator
Anthony Tang, MD FRCPC
PRINCIPAL INVESTIGATOR
London Health Sciences Centre
Frequently Asked Questions
Who can join the NCT05452356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05452356 currently recruiting?
Yes, NCT05452356 is actively recruiting participants. Contact the research team at Nellie.Kamkar@lhsc.on.ca for enrollment information.
Where is the NCT05452356 trial being conducted?
This trial is being conducted at London, Canada.
Who is sponsoring the NCT05452356 clinical trial?
NCT05452356 is sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. The principal investigator is Anthony Tang, MD FRCPC at London Health Sciences Centre. The trial plans to enroll 2,000 participants.